Pharmaceutical, Medical Device and Combination Device Testing
Cormica Appoints Rob States as Vice President of Technical Services to Strengthen Global Testing Capabilities
Cormica, a leading provider of comprehensive testing solutions for the pharmaceutical, medical device and combination product sectors, is pleased to announce the appointment of Rob States as Vice President of Technical Services. Rob brings over two decades of leadership and technical experience in MedTech and pharmaceutical industries, reinforcing Cormica’s commitment to advancing patient safety and accelerating global product development.
Rob States is a recognised industry veteran with a strong record of supporting global clients across development strategies, risk management, remediation, supply chain optimisation, testing strategies and process development. Throughout his career, Rob has contributed to the successful launch of more than 50 products and devices, supported over a dozen patents and delivered over 1,000 projects.
Rob States
Vice President of Technical Services
In addition to his consulting background, Rob has served as an advisor to start-up companies, held a board-level position, and played a role in M&A activities. He remains actively involved in several industry groups and continues to contribute to shaping best practices within the sector. Rob holds a degree in Plastics Engineering and an MBA, combining technical depth with strategic insight.
Mark Hammond
CEO
Commenting on the appointment, Mark Hammond, CEO of Cormica said:
“We are delighted to welcome Rob States to Cormica. His proven leadership, technical expertise and client-focused mindset align perfectly with our mission to support customers through every stage of the product lifecycle, from development to post-market surveillance.”
Rob will oversee Cormica’s global technical services function, supporting clients across its UK, US and EU laboratories with a consistent, science-led approach to regulatory compliance and testing excellence.
About Cormica
Cormica Group (formerly known as WMP Group) is a medical device and pharmaceuticals testing group enabling life science manufacturers and med tech innovators to launch their products more quickly, more safely and to more markets. Limerston Capital LLP acquired Wickham Microbiology Ltd in September 2021 and Medical Engineering Technologies in May 2022, with Zwizler Laboratorium and Focus Labs both in January 2025, forming Cormica Group as the collective Group operates as today.
Contact Us
Ready to take the next step? We’d love to hear from you. Contact us today to discuss your testing needs and find out how Cormica can help you achieve your goals.